应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
XLO XILIO THERAPEUTICS, INC.
盘后交易 11-26 18:38:23 EST
0.9924
+0.1108
+12.57%
盘后
0.9924
+0.0000
0.00%
16:57 EST
最高
1.04
最低
0.8500
成交量
21.02万
今开
0.8811
昨收
0.8816
日振幅
21.55%
总市值
4,362万
流通市值
2,245万
总股本
4,396万
成交额
19.41万
换手率
0.93%
流通股本
2,262万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Xilio Therapeutics Inc 预计每股亏损25美分 - 财报前瞻
Reuters · 11-07
Xilio Therapeutics Inc 预计每股亏损25美分 - 财报前瞻
Xilio Therapeutics(XLO.US):2024年Q1财报实现营收0美元,前值为0美元,预期值为3000万美元;
智通财经 · 05-14
Xilio Therapeutics(XLO.US):2024年Q1财报实现营收0美元,前值为0美元,预期值为3000万美元;
暂无数据
公司概况
公司名称:
XILIO THERAPEUTICS, INC.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Xilio Therapeutics, Inc.于2020年6月18日在特拉华州注册成立。该公司是一家生物技术公司,专注于利用免疫系统实现深度和持久的临床反应,以改善癌症患者的生活。该公司已经建立了他们的地理精确解决方案或GPS平台,以快速设计新分子,包括细胞因子和其他生物制剂,这些分子旨在通过在地理上定位肿瘤内的活动来优化其治疗指数。该公司正在通过不同的发展阶段推进一些地理上精确或肿瘤选择性的药物。该公司还计划继续利用其GPS平台开发其他免疫疗法,包括具有一系列肿瘤靶向方法的候选产品。
发行价格:
--
{"stockData":{"symbol":"XLO","market":"US","secType":"STK","nameCN":"XILIO THERAPEUTICS, INC.","latestPrice":0.9924,"timestamp":1732654800000,"preClose":0.8816,"halted":0,"volume":210244,"hourTrading":{"tag":"盘后","latestPrice":0.9924,"preClose":0.9924,"latestTime":"16:57 EST","volume":1306,"amount":1298.3271847,"timestamp":1732658260816},"delay":0,"floatShares":22617700,"shares":43958074,"eps":-1.420512,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.1108,"latestTime":"11-26 18:38:23 EST","open":0.8811,"high":1.04,"low":0.85,"amount":194063.1276866,"amplitude":0.215517,"askPrice":1.03,"askSize":100,"bidPrice":0.9593,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.420512,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732669200000},"adr":0,"listingDate":1634875200000,"adjPreClose":0.8816,"preHourTrading":{"tag":"盘前","latestPrice":0.8812,"preClose":0.8816,"latestTime":"08:39 EST","volume":2,"amount":1.7624,"timestamp":1732628388636},"postHourTrading":{"tag":"盘后","latestPrice":0.9924,"preClose":0.9924,"latestTime":"16:57 EST","volume":1306,"amount":1298.3271847,"timestamp":1732658260816},"volumeRatio":1.040899},"requestUrl":"/m/hq/s/XLO/tweets","defaultTab":"tweets","newsList":[{"id":"2481188043","title":"Xilio Therapeutics Inc 预计每股亏损25美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481188043","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481188043?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:10","pubTimestamp":1730988606,"startTime":"0","endTime":"0","summary":" * Xilio Therapeutics Inc 将于11月9日公布截至2024年9月30日的财报(估计),预计季度收入将有所增长。* 根据LSEG的数据,2位分析师的平均预期显示,这家总部位于美国马萨诸塞州沃尔瑟姆市的公司预计将实现营收330万美元。* LSEG 分析师对 Xilio Therapeutics Inc 的平均预期是每股亏损 25 美分。* 华尔街对 Xilio Therapeutics Inc 的 12 个月目标价中位数为 5.50 美元,高于其上一次收盘价 1.29 美元。11月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","LENZ"],"gpt_icon":0},{"id":"2435651587","title":"Xilio Therapeutics(XLO.US):2024年Q1财报实现营收0美元,前值为0美元,预期值为3000万美元;","url":"https://stock-news.laohu8.com/highlight/detail?id=2435651587","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435651587?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:07","pubTimestamp":1715692064,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","XLO","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xiliotx.com","stockEarnings":[{"period":"1week","weight":-0.0933},{"period":"1month","weight":-0.072},{"period":"3month","weight":-0.0311},{"period":"6month","weight":-0.0581},{"period":"1year","weight":-0.256},{"period":"ytd","weight":0.6029}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xilio Therapeutics, Inc.于2020年6月18日在特拉华州注册成立。该公司是一家生物技术公司,专注于利用免疫系统实现深度和持久的临床反应,以改善癌症患者的生活。该公司已经建立了他们的地理精确解决方案或GPS平台,以快速设计新分子,包括细胞因子和其他生物制剂,这些分子旨在通过在地理上定位肿瘤内的活动来优化其治疗指数。该公司正在通过不同的发展阶段推进一些地理上精确或肿瘤选择性的药物。该公司还计划继续利用其GPS平台开发其他免疫疗法,包括具有一系列肿瘤靶向方法的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.129773},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.018217},{"month":3,"riseRate":0.333333,"avgChangeRate":0.000519},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.165578},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.062479},{"month":6,"riseRate":0,"avgChangeRate":-0.096779},{"month":7,"riseRate":0.666667,"avgChangeRate":0.02906},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.106949},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.015843},{"month":10,"riseRate":0.666667,"avgChangeRate":0.151443},{"month":11,"riseRate":0.25,"avgChangeRate":-0.229304},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.089095}],"exchange":"NASDAQ","name":"XILIO THERAPEUTICS, INC.","nameEN":"XILIO THERAPEUTICS, INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"XILIO THERAPEUTICS, INC.(XLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供XILIO THERAPEUTICS, INC.(XLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"XILIO THERAPEUTICS, INC.,XLO,XILIO THERAPEUTICS, INC.股票,XILIO THERAPEUTICS, INC.股票老虎,XILIO THERAPEUTICS, INC.股票老虎国际,XILIO THERAPEUTICS, INC.行情,XILIO THERAPEUTICS, INC.股票行情,XILIO THERAPEUTICS, INC.股价,XILIO THERAPEUTICS, INC.股市,XILIO THERAPEUTICS, INC.股票价格,XILIO THERAPEUTICS, INC.股票交易,XILIO THERAPEUTICS, INC.股票购买,XILIO THERAPEUTICS, INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"XILIO THERAPEUTICS, INC.(XLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供XILIO THERAPEUTICS, INC.(XLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}